Cargando…

High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis

Cryptococcus spp., the causative agents of cryptococcosis, are responsible for deaths of hundreds of thousands of people every year worldwide. The drawbacks of available therapeutic options are aggravated by the increased resistance of yeast to the drugs, resulting in inefficient therapy. Also, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Julliana Ribeiro Alves, Ribeiro, Noelly Queiroz, Bastos, Rafael Wesley, Holanda, Rodrigo Assunção, Silva, Letícia Chagas, Queiroz, Estela Rezende, Santos, Daniel Assis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498649/ https://www.ncbi.nlm.nih.gov/pubmed/28680034 http://dx.doi.org/10.1038/s41598-017-04588-7

Ejemplares similares

Fluconazole Alters the Polysaccharide Capsule of Cryptococcus gattii and Leads to Distinct Behaviors in Murine Cryptococcosis
por: Santos, Julliana Ribeiro Alves, et al.
Publicado: (2014)

Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole
por: Deus, Guillem, et al.
Publicado: (2021)

Primary Cutaneous Cryptococcosis Treated with Debridement and Fluconazole Monotherapy in an Immunosuppressed Patient: A Case Report and Review of the Literature
por: Wang, Jennifer, et al.
Publicado: (2015)

Influenza A Virus as a Predisposing Factor for Cryptococcosis
por: Oliveira, Lorena V. N., et al.
Publicado: (2017)

Mutants with heteroresistance to amphotericin B and fluconazole in Candida
por: Claudino, A.L.R., et al.
Publicado: (2009)

Application of caspofungin in China compared with amphotericin B and fluconazole
por: Zhang, Chunyu, et al.
Publicado: (2014)

Amphotericin-b/fluconazole: Lack of efficacy: case report
Publicado: (2021)

Amphotericin-b/fluconazole: Lack of efficacy: case report
Publicado: (2022)

Major Role for Amphotericin B–Flucytosine Combination in Severe Cryptococcosis
por: Dromer, Françoise, et al.
Publicado: (2008)

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
por: Thompson, George R., et al.
Publicado: (2016)

Biofilm Formation and Susceptibility to Amphotericin B and Fluconazole in Candida albicans
por: Zarei Mahmoudabadi, Ali, et al.
Publicado: (2014)

Post-antifungal effect of the combination of anidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and -resistant Candida albicans
por: Vaseghi, Narges, et al.
Publicado: (2022)

Fluconazole levels in serum and cerebrospinal fluid according to daily dosage in patients with cryptococcosis and other fungal infections
por: Schiave, Letícia Aparecida, et al.
Publicado: (2017)

Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B
por: Carlson, Tyler, et al.
Publicado: (2021)

Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
por: Fay, Vanessa da Silva, et al.
Publicado: (2018)

Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole
por: Ghaffar, Muhammad, et al.
Publicado: (2019)

Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates
por: de Aquino Lemos, Janine, et al.
Publicado: (2009)

P031 Post-antifungal effect of the combination of a nidulafungin with amphotericin B and fluconazole against fluconazole-susceptible and resistant Candida albicans
por: Aslani, Narges
Publicado: (2022)

The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan
por: Yang, Yun-Liang, et al.
Publicado: (2005)

An Elderly Patient with Pulmonary Cryptococcosis with Mediastinal Lymphadenopathy Who Was Successfully Treated with Amphotericin B and Flucytosine
por: Fujimoto, Shusaku, et al.
Publicado: (2020)

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis.
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2019)

Capric acid secreted by Saccharomyces boulardii influences the susceptibility of Candida albicans to fluconazole and amphotericin B
por: Suchodolski, Jakub, et al.
Publicado: (2021)

Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans
por: Yang, Feng, et al.
Publicado: (2021)

An open label randomized controlled trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis
por: Ngan, Nguyen Thi Thuy, et al.
Publicado: (2021)

Combined effect of furanone fluconazole and amphotericin B against biofilms formed from Cryptococcus neoformans
por: Meenakumari, Kirishnamoorthy, et al.
Publicado: (2021)

The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms
por: Tóth, Zoltán, et al.
Publicado: (2022)

Recombinant vaccines of a CD4(+) T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection
por: Holanda, Rodrigo Assunção, et al.
Publicado: (2017)

Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole
por: Xu, Lijun, et al.
Publicado: (2019)

In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Candida auris Isolates
por: de-la-Fuente, Iñigo, et al.
Publicado: (2023)

Sickle Cell Anaemia Prevalence among Newborns in the Brazilian Amazon-Savanna Transition Region
por: Souza, Rayane Cristina, et al.
Publicado: (2019)

Disseminated Cutaneous Leishmaniasis, a Patient with 178 Lesions Cured with Fluconazole
por: Sousa, Anastácio Queiroz, et al.
Publicado: (2016)

A phenylthiazole derivative demonstrates efficacy on treatment of the cryptococcosis & candidiasis in animal models
por: Sá, Nívea P, et al.
Publicado: (2018)

Single-Stage Revision With Fluconazole Monotherapy in Fungal Prosthetic Knee Joint Infections
por: George, James C., et al.
Publicado: (2021)

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study
por: Chen, Yi-Chun, et al.
Publicado: (2015)

Chronic disseminated cryptococcosis without meningeal involvement in a severely immunosuppressed HIV-infected patient successfully treated with fluconazole
por: Yonekura, Tatiane da Silveira, et al.
Publicado: (2022)

Triclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformans
por: Movahed, Elaheh, et al.
Publicado: (2016)

Combined intrastromal injection of amphotericin B and topical fluconazole in the treatment of resistant cases of keratomycosis: a retrospective study
por: Nada, Waled Mahdy, et al.
Publicado: (2017)

The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans
por: Hai, Trieu Phan, et al.
Publicado: (2019)

High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the Cryptococcus neoformans Complex in Jiangxi Province, South Central China
por: Yang, Chunxi, et al.
Publicado: (2021)

Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
por: Jung, Sook-In, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l1etbl91ulnj26bj83lmaas5l5